Feds Provides Details on Plan to Integrate Hemp-Derived Products into Medicare Services
The Medicare hemp program moves forward despite litigation, signaling a major policy shift. This development expands coverage for hemp-derived products under Medicare benefits. Clinicians should stay informed about these changes to guide patient care…
Refining Cannabinoid Ratios for Geriatric Pain: Clinical and Methodological Insights
This article discusses cannabinoid ratios geriatric pain and their importance in clinical practice. Optimizing cannabinoid ratios is critical for older adults due to altered pharmacokinetics and sensitivity. Evidence-based guidance helps clinicians…
Army Raises Enlistment Age to 42 and Eases Marijuana Restrictions
The army marijuana enlistment policy now allows enlistment up to age 42 and eases marijuana restrictions. This change affects veterans' cannabis use screening and clinical care. Clinicians should adapt to these evolving military cannabis policies.
Medicare’s Cannabis (CBD) Coverage Plan Ignites Federal Controversy
Medicare cannabis coverage policy is at the center of a federal controversy as CMS evaluates CBD reimbursement. This policy shift highlights tensions between federal regulations and clinical interest in cannabinoid therapeutics. Clinicians should stay…
Feds Detail Medicare Coverage Plan for Hemp CBD and THC Products
Medicare hemp CBD THC coverage is set to expand, offering up to $500 for eligible patients. This plan introduces new prescribing opportunities for clinicians. Understanding this coverage is crucial for managing patient care effectively.
Cannabis Use Linked to Larger Brain Volume and Better Cognition in Older Adults
This study on cannabis brain volume cognition older adults reveals associations with larger brain volumes and better cognitive function. The findings challenge previous beliefs about cannabis causing cognitive decline in older adults. Clinicians should…
In the Mix: 11 More Articles — March 24, 2026
This post presents cannabis clinical updates March 24 2026, featuring 11 articles reviewed below the clinical relevance threshold. Topics include aging-related immune dysfunction, regulatory enforcement, and product innovation. These updates provide…
New Research Highlights Cannabinoids’ Potential for Liver and Heart Health
Recent studies highlight cannabinoids hepatoprotective properties, especially CBD and CBG, in reducing liver inflammation and lipid accumulation. These findings suggest potential benefits for patients with fatty liver disease and metabolic syndrome.…
Cannabis Compound Shows Promise in Fighting Alzheimer’s by Calming Brain Inflammation
Cannabis compounds alzheimers research highlights potential to calm brain inflammation, a key factor in neurodegeneration. Emerging evidence suggests cannabinoids may modulate neuroinflammatory pathways involved in Alzheimer's disease. Clinicians should…
Age-Dependent Psychiatric Risks in Cannabis Use Disorder
Cannabis use disorder psychiatric risks are significantly higher in younger patients, requiring age-stratified clinical assessment. Early intervention is crucial to prevent serious mental illness progression. Clinicians must tailor counseling and…